BRIEF published on 10/25/2024 at 07:05, 27 days 6 hours ago BB Biotech AG publie un rapport intermédiaire avec un bénéfice net positif Investissement Bénéfice Net Rapport Intérimaire Secteur Biotechnologique Biotechnologie BB
BRIEF published on 10/25/2024 at 07:05, 27 days 6 hours ago BB Biotech AG Releases Interim Report with Positive Net Profit Investment Net Profit Biotech Sector Interim Report BB Biotech
BRIEF published on 10/25/2024 at 07:05, 27 days 6 hours ago BB Biotech : Réallocation stratégique du portefeuille dans un contexte de marchés volatils Résultats Financiers Stratégie D'investissement Secteur Biotechnologique Biotechnologie BB Réaffectation Du Portefeuille
BRIEF published on 10/25/2024 at 07:05, 27 days 6 hours ago BB Biotech: Strategic Portfolio Reallocation Amid Volatile Markets Financial Results Investment Strategy Biotech Sector BB Biotech Portfolio Reallocation
PRESS RELEASE published on 10/25/2024 at 07:00, 27 days 6 hours ago EQS-Adhoc: BB Biotech AG publishes its interim report BB Biotech AG publishes its interim report for the first nine months of 2024, showing a net profit and strategic investment details Investment Company Net Profit BB Biotech AG Interim Report Stocks
PRESS RELEASE published on 10/25/2024 at 07:00, 27 days 6 hours ago BB Biotech: Strategic reallocation of portfolio assets progressing BB Biotech AG reports strategic portfolio reallocation progress in Q3 2024 amid market volatility, focusing on promising biotech investments. Key companies achieve milestones Investment BB Biotech AG Biotech Sector Milestones Portfolio Reallocation
BRIEF published on 10/23/2024 at 10:17, 29 days 2 hours ago BB Biotech Sees Positive Developments Amid Sector Challenges Investment Opportunity Biotech Sector BB Biotech Share Price Discount RNA Editing
BRIEF published on 10/23/2024 at 10:17, 29 days 2 hours ago BB Biotech constate une évolution positive malgré les défis du secteur Opportunité D'investissement Secteur Biotechnologique Biotechnologie BB Édition D'ARN Rabais Sur Le Prix De L'action
PRESS RELEASE published on 10/23/2024 at 10:12, 29 days 3 hours ago Edison issues report on BB Biotech (BION) Edison releases report on BB Biotech, highlighting positive developments in genetic medicine and revenue prospects, offering investment opportunity at a wide discount Investment Opportunity Edison Discount BB Biotech Genetic Medicine
BRIEF published on 07/26/2024 at 07:05, 3 months 26 days ago BB Biotech AG Publishes Interim Report and Announces Leadership Change Investment Management Net Profit Interim Report Leadership Change BB Biotech
Published on 11/21/2024 at 13:00, 15 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 15 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 15 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 15 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 15 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 40 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 45 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 6 hours 17 minutes ago Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 17 hours 8 minutes ago Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 17 hours 55 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
